RxDoctor Payments Data

Norio Fukami, MD

Gastroenterology · Scottsdale, AZNPI 1255425930

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 53.8% of the total. Among gastroenterology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$214,610in general payments, 2019–2025

Across 251 payments — averaging $855.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$115K
  • Creo Medical Inc.$64K
  • Olympus Corporation$20K
  • Conmed Corporation$6K
  • Steris Corporation$3K
  • Olympus Corporation Of The Americas$2K
  • plus $4K from 8 others

What the payments were for

  • Consulting fees$69,16732%
  • Speaking & faculty fees$97,00845%
  • Travel & lodging$38,92318%
  • Food & beverage$9,5124%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$214,610 in reported general payments places this provider in the 95th percentile of 355 gastroenterology providers in Arizona.

See all gastroenterology providers in Arizona

Medicare billing

Part B allowed, 2024
$87,964
Medicare patients
200
Services billed
522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase11$14,640
Omeprazole21$163
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$94

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →